Wedbush Adds HealthSpring to Its Best Ideas List

Wedbush is out with its report today on HealthSpring HS, adding HS to its Best Ideas List. In its report, Wedbush writes, "The Wedbush Investment Committee is adding HS to the Best Ideas List. We believe the company 1) has a sustainable cost advantage derived from owning clinics and high-quality star ratings, 2) is likely to deploy capital in the near term in what we believe will be an acquisition that is up to $0.30 per share accretive, and 3) is highly levered to the Medicare growth cycle." Wedbush maintains a $50 PT on HS. At the time of posting, shares of HS were trading at $35.72, down 0.31% from Tuesday's close.